Track the CAN stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, CAN has logged 2 insider filings. Market capitalisation: €5m. The latest transaction was disclosed on 29 June 2026 (Cease Substantial Holding). Among the most active insiders: 129 188 450 REGAL PARTNERS LIMITED. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
CAN 是一家在医疗保健和制药领域运营的公司。它在 XASX 市场上市。